We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+15.88%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.52B
AUM Growth
+$72.5M
Cap. Flow
-$111M
Cap. Flow %
-7.32%
Top 10 Hldgs %
40.87%
Holding
162
New
22
Increased
37
Reduced
54
Closed
28

Top Sells

Rank Stock Value
1
PM icon
Philip Morris
PM
+$25.8M
2
AB icon
AllianceBernstein
AB
+$20.1M
3
HES
Hess
HES
+$17.1M
4
BIDU icon
Baidu
BIDU
+$16.3M
5
TGTX icon
TG Therapeutics
TGTX
+$11.6M

Sector Composition

Rank Sector Weight
1 Healthcare 21.94%
2 Consumer Discretionary 9.33%
3 Financials 7.76%
4 Industrials 6.88%
5 Materials 4.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VAL icon
101
Valaris
VAL
$5.48B
$1.58M 0.1%
37,500
-2,500
-6% -$94K
BLUWU
102
Blue Water Acquisition Corp III Unit
BLUWU
$1.5M 0.1%
+150,000
New +$1.5M
SVM
103
Silvercorp Metals
SVM
$2.07B
$1.48M 0.1%
350,000
-100,000
-22% -$387K
MODD icon
104
Modular Medical
MODD
$12.9M
$1.43M 0.09%
63,987
-2,013
-3% -$53.8K
HYLN icon
105
Hyliion Holdings
HYLN
$635M
$1.12M 0.07%
850,000
-100,000
-11% -$146K
THRD
106
DELISTED
Third Harmonic Bio
THRD
$1.09M 0.07%
200,000
GUTS icon
107
Fractyl Health
GUTS
$109M
$1.04M 0.07%
645,000
-5,000
-0.8% -$8.08K
LWACU
108
LightWave Acquisition Corp Units
LWACU
$1.01M 0.07%
+100,000
New +$1M
STTK icon
109
Shattuck Labs
STTK
$675M
$867K 0.06%
1,095,000
+45,000
+4% +$43.6K
OYSEU
110
Oyster Enterprises II Acquisition Corp Units
OYSEU
$759K 0.05%
+75,000
New +$756K
IRS.WS
111
DELISTED
IRSA Inversiones y Representaciones S.A. Warrants
IRS.WS
$746K 0.05%
443,824
-3,193,350
-88% -$4.62M
PYXS icon
112
Pyxis Oncology
PYXS
$168M
$600K 0.04%
545,000
-5,000
-0.9% -$5.63K
MRSN
113
DELISTED
Mersana Therapeutics
MRSN
$589K 0.04%
79,600
+13,600
+21% +$120K
QURE icon
114
PUT
uniQure
QURE
$3.03B
$523K 0.03%
+37,500
New +$504K
SOLV icon
115
Solventum
SOLV
$14.8B
$493K 0.03%
6,500
-43,500
-87% -$3.08M
CYPH
116
Cypherpunk Technologies Inc
CYPH
$62.9M
$429K 0.03%
1,444,143
-5,757
-0.4% -$2.1K
RVPH
117
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$381K 0.03%
+50,000
New +$779K
GOSS icon
118
CALL
Gossamer Bio
GOSS
$82.9M
$369K 0.02%
+300,100
New +$327K
CRESW
119
DELISTED
Cresud SACIF y A. Warrant
CRESW
$90.5K 0.01%
107,733
-1,623,918
-94% -$1.39M
WLACW
120
DELISTED
Willow Lane Acquisition Corp Warrants
WLACW
$90K 0.01%
250,000
GCTS.WS
121
GCT Semiconductor Holding Warrants
GCTS.WS
$15M
$75.1K ﹤0.01%
775,000
SAFX
122
XCF Global Inc
SAFX
$145M
$73.3K ﹤0.01%
+41,667
New +$258K
IMUX icon
123
Immunic
IMUX
$190M
$43.6K ﹤0.01%
6,246
-83,754
-93% -$769K
CRGOW icon
124
Freightos Ltd Warrant
CRGOW
$1.73M
$38.8K ﹤0.01%
195,000
BRLSW icon
125
Borealis Foods Inc Warrant
BRLSW
$18K ﹤0.01%
200,000

Similar funds

683 Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, 683 Capital Management held 162 positions worth $1.52B, up 5% from $1.45B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

683 Capital Management withdrew a net $111M in Q2 2025, closing 28 positions and reducing 54 holdings. Its most notable exit was AllianceBernstein, an estimated $20.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, 683 Capital Management opened a new position in Barrick Mining worth $28.6M.

  • 683 Capital Management's largest Q2 2025 buy was Barrick Mining: 1,375,000 shares worth $28.6M.
  • 683 Capital Management added most to Sarepta Therapeutics in Q2 2025, an estimated $21.8M increase.
  • 683 Capital Management's biggest Q2 2025 reduction was Philip Morris, cutting an estimated $25.8M.
  • 683 Capital Management fully exited AllianceBernstein in Q2 2025, selling an estimated $20.1M.
  • 683 Capital Management's ten largest holdings make up 41% of its $1.52B portfolio in Q2 2025.
  • 683 Capital Management opened 22 new positions and closed 28 in Q2 2025.
  • 683 Capital Management's portfolio value rose 5% quarter-over-quarter to $1.52B.

Based on 683 Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.